In this section of GMP-inspection.com, our translators provide definitions and explanations of various specialized terms from the pharmaceutical industry and GMP (Good Manufacturing Practice).
Major deficiencies are violations of Good Manufacturing Practice (GMP) requirements that pose a potential risk but do not directly affect the quality or safety of a drug. Major deficiencies usually indicate complex problems in quality control and/or the production process. If they are not rectified in time, they can have far-reaching consequences.
The following are a few examples of violations that can be classified as major deficiencies:
Major deficiencies can have the following consequences:
Major deficiencies are indicators of complex problems. They must be rectified so that they do not develop into critical deficiencies. As a rule, regulatory authorities give a company a reasonable amount of time to rectify the problems identified and then require a report on the implementation of the corrective measures.
If your company is preparing for a GMP inspection by foreign regulatory authorities, our professional pharmaceutical interpreters would be delighted to assist you! They ensure smooth communication between inspection team and your company.
We also offer other services such as consulting, representation of foreign pharmaceutical companies and the distribution of their products in Germany. We have been working with hundreds of companies worldwide for years and can also help you to find vacancies in the pharmaceutical industry. Are you looking for a job vacancy in your dream country? Contact us by email for more information!